Role of the mixed-lineage protein kinase pathway in the metabolic stress response to obesity by Kant, Shashi et al.
University of Massachusetts Medical School 
eScholarship@UMMS 
Program in Molecular Medicine Publications 
and Presentations Program in Molecular Medicine 
2013-08-29 
Role of the mixed-lineage protein kinase pathway in the metabolic 
stress response to obesity 
Shashi Kant 
University of Massachusetts Medical School 
Et al. 
Let us know how access to this document benefits you. 
Follow this and additional works at: https://escholarship.umassmed.edu/pmm_pp 
 Part of the Biochemistry Commons, and the Cellular and Molecular Physiology Commons 
Repository Citation 
Kant S, Barrett T, Vertii A, Noh YH, Jung DY, Kim JK, Davis RJ. (2013). Role of the mixed-lineage protein 
kinase pathway in the metabolic stress response to obesity. Program in Molecular Medicine Publications 
and Presentations. https://doi.org/10.1016/j.celrep.2013.07.019. Retrieved from 
https://escholarship.umassmed.edu/pmm_pp/13 
This material is brought to you by eScholarship@UMMS. It has been accepted for inclusion in Program in Molecular 
Medicine Publications and Presentations by an authorized administrator of eScholarship@UMMS. For more 
information, please contact Lisa.Palmer@umassmed.edu. 
Cell Reports
Report
Role of the Mixed-Lineage Protein Kinase Pathway
in the Metabolic Stress Response to Obesity
Shashi Kant,1 Tamera Barrett,1 Anastassiia Vertii,1 Yun Hee Noh,1 Dae Young Jung,1 Jason K. Kim,1,2
and Roger J. Davis1,3,*
1Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA 01605, USA
2Department of Medicine, Division of Endocrinology, Metabolism and Diabetes, University of Massachusetts Medical School, Worcester,
MA 01605, USA
3Howard Hughes Medical Institute, University of Massachusetts Medical School, Worcester, MA 01605, USA
*Correspondence: roger.davis@umassmed.edu
http://dx.doi.org/10.1016/j.celrep.2013.07.019
This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works
License, which permits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are
credited.
SUMMARY
Saturated free fatty acid (FFA) is implicated in the
metabolic response to obesity. In vitro studies indi-
cate that FFA signaling may be mediated by the
mixed-lineage protein kinase (MLK) pathway that
activates cJun NH2-terminal kinase (JNK). Here, we
examined the role of the MLK pathway in vivo using
a mouse model of diet-induced obesity. The ubiqui-
tously expressed MLK2 and MLK3 protein kinases
have partially redundant functions. We therefore
compared wild-type and compound mutant mice
that lack expression of MLK2 and MLK3. MLK defi-
ciency protected mice against high-fat-diet-induced
insulin resistance and obesity. Reduced JNK acti-
vation and increased energy expenditure contribute
to the metabolic effects of MLK deficiency. These
data confirm that the MLK pathway plays a critical
role in the metabolic response to obesity.
INTRODUCTION
Obesity represents a major risk factor for the development of
type 2 diabetes. Metabolic stress caused by saturated free fatty
acids (FFA) may mediate this effect of obesity (Kahn et al., 2006).
Indeed, increased amounts of FFA in blood cause insulin
resistance, a hallmark of metabolic syndrome (prediabetes).
FFA can therefore cause hyperinsulinemia and can lead to b
cell failure and diabetes. An understanding of the mechanisms
that mediate FFA signaling is therefore important for the pre-
vention and treatment of diabetes.
The cJun NH2-terminal kinase signal transduction pathway
plays a key role in the development of insulin resistance (Sabio
and Davis, 2010). Indeed, feeding a high-fat diet (HFD) causes
increased cJun NH2-terminal kinase (JNK) activity in insulin
target tissues (Hirosumi et al., 2002). JNK is also activated by
the exposure of cells to saturated FFA (Jaeschke and Davis,
2007). The mechanism of saturated FFA-stimulated JNK activa-
tion is mediated by the mitogen-activated protein kinase
kinases (MAP2Ks) MKK4 and MKK7 (Jaeschke and Davis,
2007). Many different MAP kinase kinase kinases (MAP3Ks)
can activate the JNK pathway (Davis, 2000), but saturated
FFA-stimulated JNK activation in vitro is mediated by the
mixed-lineage protein kinase (MLK) subgroup of MAP3K
(Jaeschke and Davis, 2007). Upstream components of this
FFA signaling pathway may include Rac/Cdc42 (Sharma
et al., 2012), Src (Holzer et al., 2011), and PKC (Jaeschke
and Davis, 2007). Indeed, FFA-stimulated MLK activation could
be mediated by a Src pathway that activates Rac/Cdc42
(Kant et al., 2011). This pathway may be initiated by receptor
(Talukdar et al., 2011) or nonreceptor (Holzer et al., 2011;
Montell et al., 2001; Schmitz-Peiffer et al., 1999)-mediated
mechanisms.
Although these in vitro data implicate theMLK signal transduc-
tion pathway in the response to FFA-induced metabolic stress,
the role of this pathway in vivo has not been established. The
purpose of this study was to test whether the MLK pathway is
relevant to the metabolic stress response to obesity. We report
that the MLK pathway is critically required for diet-induced
insulin resistance and obesity. This analysis indicates that the
MLK pathway represents a potential target for the development
of drugs that may be therapeutically beneficial for the treatment
of obesity-related metabolic stress.
RESULTS
MLK Is Required for Diet-Induced Obesity
The MLK group of MAP3K is encoded by four genes (Gallo and
Johnson, 2002) that have partially redundant functions (Kant
et al., 2011). Gene expression analysis indicated that the
genes that encode MLK2 (Map3k10) and MLK3 (Map3k11)
(but not MLK1 [Map3k9] and MLK4 [Bc021891]) are highly
expressed in peripheral insulin-responsive tissues, including
white and brown adipose tissue, liver, and muscle (Figure S1).
We therefore established compound mutant Map3k10/
Map3k11/ mice to study the role of MLK in insulin-responsive
tissues.
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We examined diet-induced obesity in wild-type (WT) and
Map3k10/ Map3k11/ mice. Control studies using chow-
fed mice demonstrated that MLK-deficient mice were slightly
smaller than WT mice, but no differences in the rate of weight
gain between WT and mutant mice were detected (Figure 1A).
In contrast, the Map3k10/ Map3k11/ mice exhibited partial
resistance to HFD-induced obesity compared with WT mice
Figure 1. MLK Deficiency Protects Mice
against the HFD-Induced Obesity and Insu-
lin Resistance
(A) WT and MLK-deficient male mice (8–10 weeks
old) were fed either a chow diet (ND) or a HFD
(16 weeks). The weight of the mice was measured
(mean ± SE; n = 10).
(B) Insulin tolerance tests (ITT) on MLK-deficient
and WT mice fed either a chow diet (ND) or a HFD
(16 weeks) were performed by intraperitoneal
injection of insulin (0.75 U/kg body mass). The
concentration of blood glucose was measured
(mean ± SE; n = 10).
(C) Glucose tolerance tests (GTT) on chow-fed
(ND) and HFD-fed WT and MLK-deficient mice
were performed by measurement of blood glucose
concentration in animals following intraperitoneal
injection of glucose (2 g/kg). The data presented
represent the mean ± SE (n = 10).
(D) Glucose-induced insulin release. The effect of
administration of glucose (2 g/kg body mass) by
intraperitoneal injection on blood insulin concen-
tration was examined (mean ± SE; n = 10).
(E) Insulin sensitivity was measured using a hy-
perinsulinemic-euglycemic clamp in conscious
HFD-fed (3 weeks) WT and MLK-deficient mice.
The steady state glucose infusion rate (GIR) during
the clamp, whole body glucose turnover, hepatic
glucose production (HGP) during the clamp, the
hepatic insulin action (expressed as insulin-
mediated percent suppression of basal HGP), and
whole body glycogen plus lipid synthesis are pre-
sented (mean ± SE; n = 7  8).
(F) Sections prepared from epididymal adipose
tissue and liver of chow-fed and HFD-fed WT and
MLK-deficient mice were stained with hematoxylin
and eosin. The panels are representative of five
mice per group.
Statistically significant differences between WT
and MLK-deficient mice are indicated (*p < 0.05;
**p < 0.01; ***p < 0.001; ****p < 0.0001). See also
Figure S2.
(Figure 1A). Measurement of organ
weight at necropsy demonstrated that
the increased liver and adipose tissue
mass detected in HFD-fed WT mice
was reduced in HFD-fed Map3k10/
Map3k11/ mice (Figure S2). Analysis
of liver sections demonstrated that HFD-
induced hepatic steatosis in WT mice
was absent in MLK-deficient mice (Fig-
ure 1F). Moreover, WT adipocytes were
larger than adipocytes in Map3k10/
Map3k11/mice (Figure 1F). Together, these data demonstrate
thatMLKdeficiency protectsmice against HFD-induced obesity.
MLK Is Required for Diet-Induced Insulin Resistance
Feeding a HFD to WT mice caused reduced responsiveness
in insulin tolerance tests (Figure 1B) and glucose intolerance
(Figure 1C). In contrast, HFD-fed Map3k10/ Map3k11/
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mice showed improved insulin sensitivity in an insulin tolerance
test (Figure 1B), improved glucose tolerance (Figure 1C),
and improved glucose-induced insulin secretion (Figure 1D)
compared with HFD-fed WT mice. These data indicate that
Map3k10/ Map3k11/ mice are protected against HFD-
induced insulin resistance.
We performed a hyperinsulinemic-euglycemic clamp study to
test whether the insulin sensitivity of HFD-fed Map3k10/
Map3k11/ mice was greater than HFD-fed WT mice. This
analysis demonstrated that the glucose infusion rate during
the clamp in the MLK-deficient mice was significantly greater
than HFD-fed WT mice (Figure 1E), indicating that the
Map3k10/ Map3k11/ mice exhibited increased insulin sen-
sitivity compared to WT mice. This increased insulin sensitivity
of Map3k10/ Map3k11/ mice was associated with reduced
hepatic glucose production during the clamp and improved he-
patic insulin action compared with HFD-fedWTmice (Figure 1E).
Together, these data indicate that HFD-fed Map3k10/
Map3k11/mice exhibit increased insulin sensitivity compared
with HFD-fed WT mice. This conclusion was confirmed by
biochemical measurement of insulin-stimulated tyrosine phos-
phorylation of the scaffold protein IRS-1 (Figure 2A) and acti-
vation of the AKT signaling pathway (Figure 2B). HFD-fed
MLK-deficient mice exhibited decreased HFD-induced hyper-
insulinemia (Figure 2C) and hyperglycemia (Figure 2D) compared
with HFD-fed WT mice. Furthermore, the blood concentration
of adipokines (leptin and resistin) and inflammatory cytokines
(interleukin 1b [IL1b] and IL6) was reduced in HFD-fed MLK-defi-
cient mice compared with HFD-fed WT mice (Figures 2E–2H).
The MLK signaling pathway is implicated in the regulation
of MAP kinases. However, no defects in extracellular signal-
regulated kinase (ERK) signaling were detected in MLK-deficient
mice (Figure 2I). However, MLK deficiency reduced the acti-
vation of p38 MAP kinase and prevented the activation of JNK
caused by feeding a HFD (Figure 2I). MLK deficiency also
prevented the activation of JNK caused by FFA (Figure 2J).
These data suggest that the metabolic phenotype of MLK-
deficient mice may result from defects in stress-activated MAP
kinase signaling, including p38 and JNK.
MLK Deficiency Causes Increased Energy Expenditure
The resistance of MLK-deficient mice to HFD-induced obesity
(Figure 1A) may represent a primary metabolic phenotype in
these mice. Indeed, the reduced obesity of MLK-deficient mice
compared with WT mice (Figure 1A) may contribute to the
improved insulin sensitivity of MLK-deficient mice (Figure 1B).
We therefore examined the mechanistic basis for the obesity
phenotype of HFD-fed MLK-deficient mice. Studies using
metabolic cages indicated that the food and water intake of
chow-fed WT and MLK-deficient mice was similar (Figure 3).
However, the MLK-deficient mice consumed significantly more
food and water than WT mice when fed a HFD (Figure 3). These
data do not provide an explanation for the reduced obesity
of HFD-fed MLK-deficient mice compared with HFD-fed WT
mice. Increased energy expenditure could contribute to the
lean phenotype of HFD-fed MLK-deficient mice. Indeed,
measurement of gas exchange demonstrated that VO2 and
VCO2 were significantly increased in HFD-fed Map3k10
/
Map3k11/ mice compared with HFD-fed WT mice (Figure 3).
These changes were associated with increased physical activity
(Figure 3). Collectively, these data indicate that MLK-deficient
mice are resistant to HFD-induced obesity because of increased
energy expenditure (Figure 3).
MLK Deficiency and the Hypothalamic-Pituitary-
Thyroid Axis
JNK is a target of the MLK signal transduction pathway (Gallo
and Johnson, 2002). JNK1-deficient mice, like MLK-deficient
mice (Figure 1), are resistant to HFD-induced obesity (Hirosumi
et al., 2002). Tissue-specific Jnk1 gene ablation studies
have established that central actions of JNK1 in the brain are
responsible for this obesity phenotype (Sabio and Davis, 2010).
Specifically, neuronal JNK1 deficiency acts through the hypo-
thalamic-pituitary-thyroid axis to increase energy expenditure
and suppress HFD-induced obesity (Sabio and Davis, 2010).
This mechanism could account for the phenotype of MLK-
deficient mice. Neuronal JNK1 deficiency causes central
hyperthyroidism by increasing the expression of thyrotropin-
releasing hormone (TRH) in the hypothalamus and thyroid-
stimulating hormone (TSH) in the anterior pituitary gland
(Sabio et al., 2010). In contrast, we found that MLK deficiency
caused reduced TRH and TSH expression (Figure S3). These
data indicate that the central hyperthyroidism of JNK1-deficient
mice was not detected in MLK-deficient mice.
It is established that thyroid hormone causes feedback inhibi-
tion of TRH and TSH expression (Chiamolera and Wondisford,
2009). The decreased TRH and TSH expression inMLK-deficient
mice may therefore result from increased thyroid hormone
signaling. To test this hypothesis, we examined the expression
of thyroid hormone responsive genes (Ldhb, Ucp1, Pck1,
Slc2A4, and Thrsp) in the brown fat of WT and Map3k10/
Map3k11/ mice. We found that MLK deficiency increased
thyroid hormone responsive gene expression in brown fat
(Figure S4A). To test whether this increased thyroid hormone
responsiveness might contribute to the metabolic phenotype
of MLK-deficient mice, we treated WT and MLK-deficient mice
with propylthiouracil (PTU), a drug that inhibits thyroperoxidase
and prevents T4 production by the thyroid gland (Bjo¨rkman
and Ekholm, 2000). We found no significant differences in
obesity, insulin tolerance, and blood concentrations of glucose
and insulin between PTU-treated HFD-fed WT and MLK-
deficient mice (Figures S4B–S4G). These data indicate that
thyroid hormone contributes to the metabolic phenotype of
MLK-deficient mice. Nevertheless, the MLK-deficient mice, un-
like JNK1-deficient mice, do not exhibit central hyperthyroidism.
MLK Deficiency and the Autonomic Nervous System
The hypothalamic-pituitary-thyroid axis may not represent a
direct target of MLK signaling (Figure S3). Nevertheless, the
hypothalamic-pituitary-thyroid axis may be indirectly targeted
by MLK deficiency through the autonomic nervous system.
Indeed, it is established that the sympathetic nervous system,
including the sympathoadrenal system, collaborates with the
hypothalamic-pituitary-thyroid axis to regulate energy expendi-
ture (Silva and Bianco, 2008). To test whether this is relevant to
the phenotype of MLK-deficient mice, we examined brown fat
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Figure 2. MLK Deficiency Reduces HFD-Induced JNK Activation and Suppression of AKT
(A and B) Chow-fed (ND) and HFD -fed WT and MLK-deficient mice (16 weeks) were fasted overnight and then treated by intraperitoneal injection of saline
(control) or 1.5 U/kg insulin (15 min). Extracts prepared from epididymal fat pads were examined by (A) immunoprecipitation with an antibody to IRS-1 and
immunoblot analysis with antibodies to IRS-1/phosphotyrosine and (B) immunoblot analysis using antibodies to pThr308-AKT, pSer473-AKT, and AKT (upper
panel) and bymultiplexed ELISA (lower panel). Relative AKT phosphorylation (calculated as the ratio pSer473-AKT/AKT) is presented (mean ± SE; n = 6; *p < 0.05).
(C–H)WT andMLK-deficient mice were fed a chow diet (ND) or a HFD (16 weeks) and starved overnight. The blood concentrations of insulin (E), glucose (F), leptin
(G), resistin (H), IL1b (I), and IL6 (J) are presented (mean ± SE; n = 10). Statistically significant differences between MLK-deficient and WT mice are indicated
(*p < 0.05; **p < 0.01).
(I) MAPK activation in epididymal adipose tissue of WT and MLK-deficient mice was measured by immunoblot analysis by probing with antibodies to MAPK and
phospho-MAPK.
(J) WT and MLK-deficient primary embryo fibroblasts were treated with 0.5% (w.v.) BSA or 0.75 mM palmitate/0.5% BSA (16 hr). Cell lysates were examined by
immunoblot analysis with antibodies to pJNK and JNK.
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in chow-fed and HFD-fed Map3k10/ Map3k11/ mice.
Control studies using WT mice demonstrated that feeding a
HFD caused an increase in interscapular brown fat mass (Fig-
ure S2). This increase in brown fat mass was suppressed in
HFD-fed Map3k10/ Map3k11/ mice (Figure S2). Sections
prepared from interscapular brown fat demonstrated that
HFD-induced hypertrophy of brown adipocytes in WT mice
was reduced inMap3k10/Map3k11/mice (Figure 4I). These
data are consistent with increased sympathetic neuronal stimu-
lation of brown fat metabolic activity in MLK-deficient mice.
We found increased amounts of epinephrine and norepi-
nephrine in the blood (Figures 4A and 4B) and increased
expression of the adrenergic target genes Lpl (Carneheim
et al., 1984), Dio2 (Silva and Larsen, 1983), and Ppargc1a
(Puigserver et al., 1998) in brown fat of MLK-deficient mice
compared with WT mice (Figures 4D, 4G, and 4H). Dio2
expression causes increased intracellular conversion of T4 to
T3 and occupancy of the thyroid hormone receptor (Bianco
et al., 2002), while Ppargc1a expression increases peroxisome
proliferator-activated receptor g (PPARg) transcriptional
activity (Handschin and Spiegelman, 2006). The thyroid hor-
mone receptor, PPARg, and cyclic AMP response element-
binding protein represent mediators of thermogenic gene
expression in brown fat (Cannon and Nedergaard, 2004).
Map3k10/ Map3k11/ mice exhibit increased expression
of Ucp1 and Ucp3 in brown fat (Figures 4E and 4F) and
increased body temperature (Figure 4C) compared with WT
mice. Together, these data indicate that brown fat thermogen-
esis is increased in Map3k10/ Map3k11/ mice compared
with WT mice.
The b3 adrenergic receptor can mediate effects of the sym-
pathetic nervous system and circulating epinephrine on brown
fat (Cannon and Nedergaard, 2004). To test the role of adren-
ergic regulation of brown fat in MLK-deficient mice, we treated
mice with the selective b3 receptor antagonist SR59230A
(Nisoli et al., 1996). This analysis demonstrated that b3 receptor
blockade prevented the increased body temperature (Figure 4J)
and the increased expression of Ppargc1a, Ucp1, and Ucp3 in
brown fat (Figures 4K–4M) caused by MLK deficiency. Together,
these data demonstrate that the sympathoadrenal system
contributes to the increased energy expenditure detected in
MLK-deficient mice.
DISCUSSION
The MLK pathway is implicated as a mediator of saturated FFA
signaling that causes JNK activation and insulin resistance
(Jaeschke and Davis, 2007). Biochemical studies using cultured
primary cells provide strong support for this conclusion
(Jaeschke and Davis, 2007). However, the role of the MLK
pathway in vivo has not been established. In this study, we
tested whether the MLK pathway contributes to insulin resis-
tance and obesity caused by feeding a HFD.
Four members of the MLK family have been identified (Gallo
and Johnson, 2002). We found that two MLK isoforms (MLK2
and MLK3) are expressed ubiquitously. In contrast, all four
MLK isoforms are detected in the brain. These MLK isoforms
serve partially redundant functions (Kant et al., 2011). We there-
fore examined the effect of compound mutation of the MLK
isoforms that are expressed in insulin target tissues. The HFD-
fedMLK-deficient mice exhibited reduced obesity and improved
hyperinsulinemia and hyperglycemia compared with HFD-fed
WT mice. Moreover, these MLK-deficient mice have improved
insulin sensitivity, improved glucose tolerance, and improved
glucose-induced insulin secretion compared with WT mice
when fed a HFD. Collectively, these data demonstrate that the
MLK pathway plays an essential role in the metabolic stress
response to feeding a HFD.
Figure 3. MLK Deficiency Causes Increased Energy Expenditure
Food and water consumption, gas exchange (VO2 and VCO2), energy expen-
diture, and physical activity were measured using metabolic cages (mean ±
SE; n = 6). Statistically significant differences between WT and MLK-deficient
mice are indicated (*p < 0.05; **p < 0.01; ***p < 0.001).
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Figure 4. The Sympathoadrenal System Causes Increased Thermogenesis in Mlk2/ Mlk3/ Mice
(A and B) WT andMLK-deficient mice were fed a chow diet (ND) or a HFD (16 weeks). The blood concentration of epinephrine and norepinephrine was measured
(mean ± SE; n = 8).
(C) The body temperature of the mice was measured (mean ± SE; n = 8).
(D–H) The expression of Dio2 (D), Ucp1 (E), Ucp3 (F), Ppargc1a (G), and Lpl (H) messenger RNA (mRNA) expression in interscapular brown fat was measured
by quantitative RT-PCR and was normalized to the amount of Gapdh mRNA in each sample (mean ± SE; n = 8).
(I) Sections prepared from interscapular brown fat of chow-fed (ND) and HFD-fed WT and MLK-deficient mice were stained with hematoxylin and eosin. The
panels presented are representative of five mice per group.
(J) The body temperature of WT and MLK-deficient mice was measured (mean ± SE; n = 10). The effect of treatment of the mice with solvent (control) or the b3
adrenergic receptor antagonist SR59230A was examined.
(K–M) The expression of Ppargc1a (K), Ucp1 (L), and Ucp3 (M) mRNA expression in brown fat was measured by quantitative RT-PCR and was normalized to the
amount of Gapdh mRNA in each sample (mean ± SE; n = 10).
Statistically significant differences between WT and MLK-deficient mice are indicated (*p < 0.05; **p < 0.01).
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The effect of MLK deficiency to protect against HFD-induced
insulin resistance may be mediated by reduced JNK activation
(Sabio and Davis, 2010). Indeed, MLK deficiency suppressed
HFD-induced p38MAPK activation and prevented HFD-induced
JNK activation. These defects in stress-activated MAPK regu-
lation may contribute to the metabolic phenotype of MLK-
deficient mice. However, the lean phenotype of HFD-fed
MLK-deficient mice may also contribute to improved insulin
sensitivity. Metabolic cage studies demonstrated that this lean
phenotype was not caused by a reduction in food intake but
was associated with a large increase in energy expenditure.
Previous studies have implicated the hypothalamic-pituitary-
thyroid axis in JNK-mediated regulation of energy expenditure
(Belgardt et al., 2010; Sabio et al., 2010). These studies have
identified a role for JNK in the negative regulation of the hypo-
thalamic-pituitary-thyroid axis by thyroid hormone (Sabio and
Davis, 2010). However, the increased expression of TRH and
TSH reported for JNK-deficient mice was not detected in
MLK-deficient mice. It is possible that redundant functions of
MLK1 and MLK4 may compensate for the deficiency of MLK2
plus MLK3 in the brains of these mice.
Although MLK-deficient mice did not exhibit the changes in
TRH and TSH expression that are detected in JNK-deficient
mice, increased thyroid hormone-dependent gene expression
was detected in the brown fat of micewithMLK2 plusMLK3 defi-
ciency compared to WT mice. It is established that intracellular
conversion of T4 to T3 is required for brown fat responsiveness
to thyroid hormone (Bianco and Silva, 1987). This conversion
is mediated by type 2 iodothyronine deiodinase, a target of
the sympathoadrenal system (Bianco et al., 2002). Indeed,
increased expression of Dio2 was detected in the brown fat of
MLK-deficient mice compared with WT mice. Together, these
data indicate that MLK deficiency may increase sympathetic
regulation of brown fat, including norepinephrine release by
nerves and epinephrine release by the adrenal gland. Moreover,
we found increased epinephrine in the blood, increased expres-
sion of thermogenic genes, and increased body temperature
of MLK-deficient mice. These changes were blocked when
MLK-deficient mice were treated with a b3 adrenergic receptor
antagonist. The sympathoadrenal system in MLK-deficient
mice therefore causes increased energy expenditure that
contributes to the protection against HFD-induced obesity.
This mechanism may also contribute to the lean phenotype of
HFD-fed JNK-deficient mice (Sabio and Davis, 2010).
It is established that the autonomic nervous system plays a
key role in the regulation of glucose homeostasis and obesity
(Kahn and Flier, 2000; Marino et al., 2011). The role of the sym-
pathetic nervous system in the phenotype of MLK-deficient
mice provides another example of the importance of metabolic
regulation by the autonomic nervous system. This mechanism
contributes to the increased energy expenditure and protection
against obesity detected in HFD-fed MLK-deficient mice. More-
over, both the lean phenotype of HFD-fed MLK-deficient mice
and the requirement of the MLK pathway for HFD-induced
JNK activation contribute to the protection of MLK-deficient
mice against HFD-induced insulin resistance. Collectively, these
data identify the MLK pathway as a key mechanism that
mediates metabolic stress responses to obesity. Moreover,
these data identify MLK as a possible drug target for the treat-
ment of obesity-related insulin resistance.
EXPERIMENTAL PROCEDURES
Mice
Map3k10/ (Kant et al., 2011), Map3k11/ mice (Brancho et al., 2005), and
compound mutant Map3k10/ Map3k11/ mice (Kant et al., 2011) were
described previously. These mice were maintained on a C57BL/6J strain
background (The Jackson Laboratories). Male mice (8–10 weeks old) were
fed a chow diet (Iso Pro 3000, Purina) or a HFD (F3282, Bioserve) for 16 weeks.
Treatment with the b3 antagonist SR59230A (2 mg/kg; Tocris Bioscience) was
performed by subcutaneous injection once each day (3 days). Mice were
treated with PTU in the drinking water (cherry-flavored Kool-Aid without or
with 1.2 mM PTU [Sigma-Aldrich]). Body temperature was measured using a
Microthermia 2 Type ‘‘T’’ Thermometer (Braintree Scientific). The mice were
housed in a facility accredited by the American Association for Laboratory
Animal Care. The animal studies were approved by the Institutional Animal
Care and Use Committee, University of Massachusetts Medical School.
Glucose and Insulin Tolerance Tests
Glucose and insulin tolerance tests were performed (Mora et al., 2005) by
intraperitoneal injection of mice starved overnight with glucose (2 mg/g of
body mass) and intraperitoneal injection of mice fed ad libitum with human
insulin (0.75 mU/g of body mass).
Analysis of Blood
Blood glucose was measured with an Ascensia Breeze 2 glucometer (Bayer).
Plasma adipokines, cytokines, and insulin were measured by ELISA (Luminex
200; Millipore). Plasma epinephrine and norepinephrine were measured using
the catecholamine assay kit Bi-CAT EIA (17-EA613-192; Alpco Diagnostics) by
following the manufacturer’s instructions.
Statistical Analysis
Differences between groups were examined for statistical significance using
the Student’s test or ANOVA with the Fisher’s test.
For additional details regarding thematerials andmethods used in this work,
see the Extended Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures and
four figures and can be found with this article online at http://dx.doi.org/
10.1016/j.celrep.2013.07.019.
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